top of page

Autism Discovery and Treatment Foundation

Making Autism History

ADTF: Work
Head Shot.jpg

Richard E Frye

Richard E. Frye, an American autism researcher with expertise in neurodevelopmental and neurometabolic disorders. He is the Director of Research at the Rossignol Medical Center. He received an MD and PhD in Physiology and Biophysics from Georgetown University. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He also received a Master’s degree in Biomedical Science and Biostatistics from Drexel University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 300 peer-reviewed publications and book chapters, and serves on several editorial boards.


Daniel Rossignol

Dr. Rossignol, MD FAAFP is a board-certified family physician. He received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. He has made it his mission to research and publish in autism. Since 2006, he has 55 papers, abstracts, editorials, and book chapters (including those in press) concerning autism and related conditions. Dr. Rossignol has a special interest in autism spectrum disorders, PANS/PANDAS, cerebral palsy, and related neurological and developmental disorders as well as medically complex children and adults. Dr. Rossignol is a Fellow of the American Academy of Family Physicians (FAAFP) and a Fellow of the Medical Academy of Pediatric Special Needs (FMAPS). Dr. Rossignol sees patients in all three offices in California and Florida.

Sunset 3_edited.jpg


The overall aim of the Autism Discovery and Treatment Fund is to improve the lives of individuals and families living with chronic diseases which have been difficult to treat and/or cure. This includes disorders such as neurodevelopmental disorders and Cancer. We aim to improving the accuracy of diagnosis and the effectiveness of treatment by identifying treatable biologically valid mechanism and causes of disease, developing and validating practical and safe treatments and educating the scientists, medical professionals and general public regarding new developments in biological mechanisms and treatments.  The fund will solicit donations for the aforementioned purpose and fund basic, translational and clinical research, including clinical trials aimed at FDA approval, and education efforts to address the aforementioned goals. The fund aims to fund projects based at our foundations, including our research laboratory and clinical sites, and promising projects championed by other researchers and educators.

ADTF: Quote


Development of Biomarkers and Treatments from Basic Research to Clinical Products that Improve Lives

ADTF: Welcome

Projected Projects

Funding and Projects

Year 1

$400k in funding and donations, Fund 3 internal basic science projects

Year 2

$1M in funding and donations, Fund 4 internal basic science projects and 1 Phase II clinical trial

Year 3

Year 3: $6M in Funding and Donations, Fund 4 internal basic science projects, 1 Phase II clinical trial, 1 Phase III clinical trial

Year 4

$8M in funding and donations, Fund 5 internal basic science projects, 2 Phase II clinical trial, 1 Phase III clinical trial

Year 5

$10M in funding and donations, Fund 6 internal basic science projects, 3 Phase II clinical trial, 1 Phase III clinical trial

ADTF: List

Scientific Publications

Conference Presentations


Parent Articles

ADTF: Projects


Thanks for submitting!

ADTF: Contact
bottom of page